Loading data for HELX — first visit, this takes a few seconds.

Franklin Genomic Advancem...

Cboe US: HELX · Precio en tiempo real · USD
43.11
+0.67 (1.58%)
Al cierre: Aug 21, 2026, 8:00 PM
43.11
+0.00%
Fuera de horario: 7:30 PM

Franklin Genomic Advancements ETF (HELX): precio, posiciones y análisis del ETF

1.58%

No hay datos disponibles

Precio de compra21.41
Capitalización de mercadon/a
AUM29.1M
NAV43.20
Beta0.99
EPS (ttm)n/a
Relación PE (ttm)36.38
Acciones en circulaciónn/a
Fecha de inicioFeb 25, 2020
Precio de venta64.23
Volumen157
Volumen medio (20D)2,519
Abierto43.11
Cierre anterior42.44
Rango del día43.11 - 43.11
Rango de 52 semanas29.32 - 43.11
Participacionesn/a
Relación de gastos0.50%

Acerca de HELX

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Clase de activo Equity
Símbolo bursátil HELX
Fecha de inicio Feb 25, 2020
Intercambio Cboe US

Sectores principales

Sector% en peso
Healthcare96.44%
Basic Materials2.65%
Technology0.91%
Ver todos los sectores

Las 10 principales participaciones 47.90% de activos

NombreSímboloPeso
Guardant Health IncGH10.09%
Natera IncNTRA7.57%
Krystal Biotech IncKRYS5.97%
Ligand Pharmaceutica...LGND4.32%
Adaptive Biotechnolo...ADPT4.32%
Bridgebio Pharma IncBBIO3.87%
United Therapeutics ...UTHR3.45%
Eli Lilly And CoLLY2.91%
Vertex Pharmaceutica...VRTX2.71%
Samsung Biologics Co...207940.KS2.69%
Ver más participaciones

Dividendos Rendimiento de dividendos 0.33%

Ex-DividendoCantidadFecha de pago
Dec 30, 2025$0.1430n/a
Dec 30, 2021$0.0040n/a
Dec 13, 2021$0.1140n/a
Dec 14, 2020$0.0520n/a
Historial completo de dividendos